United Therapeutics (UTHR) Equity Income (2009 - 2013)
United Therapeutics' (UTHR) quarterly Equity Income came in at -$72000.0 in Q2 2013, down 71.43% year-on-year from -$252000.0 in Q2 2012, and down 53.19% quarter-over-quarter from -$47000.0 in Q1 2013.
United Therapeutics (UTHR) Equity Income (2009 - 2013) Analysis & Trends
United Therapeutics has disclosed Equity Income across 5 years of filings, most recently posting -$72000.0 for Q2 2013.
- Equity Income for Q2 2013 came in at -$72000.0, down 71.43% year-over-year; the trailing twelve-month figure through Jun 2013 was -$200000.0 (down 75.44% YoY), and the FY2012 annual result was -$143000.0, down 20.17% from the prior year.
- Equity Income came in at -$72000.0 for Q2 2013 at United Therapeutics, down from -$47000.0 in the prior quarter.
- In the past five years, Equity Income ranged from a high of -$9000.0 in Q4 2011 to a low of -$72000.0 in Q2 2013.
- The 5-year median for Equity Income is -$42000.0 (2009), against an average of -$39000.0.
- Across the five-year window, Equity Income surged 70.0% in 2011 and slumped 266.67% in 2012, its largest moves.
- United Therapeutics' Equity Income stood at -$42000.0 in 2009, then increased by 28.57% to -$30000.0 in 2010, then soared by 70.0% to -$9000.0 in 2011, then plunged by 266.67% to -$33000.0 in 2012, then plunged by 118.18% to -$72000.0 in 2013.
- The last three Equity Income figures came in at -$72000.0 (Q2 2013), -$47000.0 (Q1 2013), and -$33000.0 (Q4 2012), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -1.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 25.30 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -9.68 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 14.91 Mn |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2013 | -72,000.00 |
| Mar 31, 2013 | -47,000.00 |
| Dec 31, 2012 | -33,000.00 |
| Sep 30, 2012 | -48,000.00 |
| Jun 30, 2012 | -42,000.00 |
| Mar 31, 2012 | -20,000.00 |
| Dec 31, 2011 | -9,000.00 |
| Sep 30, 2011 | -43,000.00 |
| Jun 30, 2011 | -30,000.00 |
| Mar 31, 2011 | -37,000.00 |
| Dec 31, 2010 | -30,000.00 |
| Sep 30, 2010 | -39,000.00 |
| Jun 30, 2010 | -44,000.00 |
| Mar 31, 2010 | -47,000.00 |
| Dec 31, 2009 | -42,000.00 |
| Sep 30, 2009 | -42,000.00 |
| Jun 30, 2009 | -38,000.00 |